Zhongjing Capital
VC Fund
Chaoyang, China
Zhongjing capital is a private equity investment management institution.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Zhongjing Capital invests in
Stages Zhongjing Capital invests in
Countries Zhongjing Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Li Shihua
|
|||
Investment Focus
Industry
- Venture Capital 2 (29%)
- Financial Services 2 (29%)
- Finance 1 (14%)
- Biopharma 1 (14%)
- Life Science 1 (14%)
Stage
- Private Equity 4 (57%)
- Series B 2 (29%)
- Seed 1 (14%)
Country
- China 5 (71%)
- Hong Kong 1 (14%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Li Shihua
Managing Partner
|
Managing Partner | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Dolphin Intelligence
|
Dolphin Intelligence focuses on large-model multimodal and edge computing technologies. Dolphin Intelligence specializes in AI-enhanced ultrasound equipment designed for primary medical applications. Their solutions aim to improve diagnostic efficiency and accessibility in healthcare. | Seed / Apr 02, 2025 | |
|
|
Yichao Medical Technology is a medical equipment manufacturer.It provides E-ultrasound equipments. | $13.8M / Series B / Apr 05, 2024 | |
|
|
Verity venture focuses on the active organization model, invests in an entrepreneurial way | Private Equity / Jan 01, 2024 | |
|
|
Great Bay Bio Ltd. is a high-tech company that develops blue ocean biopharmaceuticals with a digital platform. It has a long history of biomedical research and development and rich experience in product development. Adhering to the national strategic concept of scientific and technological innovation and coordinated development of the Greater BayArea, Dawan Biotechnology brings together high-quality resources from Europe, the United States, Singapore, and Hong Kong to build a biopharmaceutical development platform centered on AI technology, big data, and Internet of Things technology, which greatly shortens The drug development cycle significantly reduces development costs and has great industry competitive advantages. | $15M / Series B / Sep 13, 2022 | |
|
|
Founded by Mr. Hesong Tang and Ms. Maggie Yang, Xiang He Capital is a venture capital fund focusing on early and growth stage investments in TMT industry in China. Before starting Xiang He, Mr. Tang was Baidu's VP of Corporate Development, overseeing strategic investments and M&A, and Ms. Yang was Baidu's Managing Director ofCorporate Development. They have led a series of landscape-changing deals such as iQiyi, Qunar, PPS and 91 wireless, which all have a significant impact on China's TMT industry.Xiang He's team have a background from Corporate Development of Baidu, other leading internet companies, and VC funds. The team is particularly strong in strategic analysis and has deep connections in the internet industry. Xiang He's investments are driven by strategic analysis and collective wisdom. | Private Equity / Jan 01, 2022 | |
|
|
Alwin Capital is a venture capital that specializes in early-stage life science investments.Driven by theme-focused research in life science, Alwin Capital has developed investment strategies that capture outstanding opportunities for innovative diagnostic and therapeutic developments. We are committed to the long-term investment in life sciencewith the pursuit of the excess investment return based on scientific insights.Founded in 2015, Alwin Capital was formed by former CICC senior executives, bringing in decades of experience in healthcare research and medical markets. Alwin Capital currently manages three venture funds with more than RMB 1 Billion in AUM, has invested in dozens of companies in life science, and cultivated a bunch of leading companies in respective segments. | Private Equity / Jan 01, 2021 | |
|
|
JOY CAPITAL invests in startups of both early and growth stages and focuses on TMT and innovative consumption sectors. “Do Hard Things with JOY”. JOY CAPITAL keeps partnering with entrepreneurs for helping them make right decisions at key moments during a startup’s developments and sharing the hardship and joy with them while starting theirbusiness. Founding partners of JOY CAPITAL have invested in more than 80 startups and over 10 portfolios they’ve invested in are unicorns. | Private Equity / Jan 01, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Zhongjing Capital invest in?
Zhongjing Capital invests primarily in Venture Capital, Financial Services and Finance startups, most often at Private Equity and Series B stage. Most of the 7 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Zhongjing Capital?
Public channels for Zhongjing Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Zhongjing Capital?
The team at Zhongjing Capital includes Li Shihua (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!